Get research updatesSchizophrenia can affect how a person perceives reality, thinks and feels, sometimes involving hearing voices or holding unusual beliefs.
Psychopharmacologic Aspects of Motor Slowing in Schizophrenia
This study has finished and is no longer accepting participants.
In San DiegoDuration of Maintenance Anti-psychotic Therapy After First -Episode Schizophrenia: a Double-blind Randomized Placebo-control Relapse Prevention Study
This study has finished and is no longer accepting participants.
In Hong Kong
Antismoking Effects of Electronic Cigarettes in Subjects With Schizophrenia and Their Potential Influence on Cognitive Functioning: Design of a Randomized Trial. Smoking Cessation And Reduction In Schizophrenia (The SCARIS Study)
This study was withdrawn before enrollment.
Location not clearly listedCerebral Mechanism Involved in Appetite Increase in Schizophrenia Patients Treated With Atypical Antipsychotics (IIT)
This study has finished and is no longer accepting participants.
In MontrealA Double-Blind Randomized Placebo Controlled Study of Aripiprazole Augmentation for Clozapine-Treated Patients With Refractory Schizophrenia
This study has finished and is no longer accepting participants.
In SeoulAripiprazole (BMS-337039) for Outpatients With Schizophrenia Completing Aripiprazole Clinical Trials: A Non-Comparative Rollover Protocol
This study has finished and is no longer accepting participants.
Multiple locations, including OttawaThis study evaluated the safety of Aripiprazole IM Depot for people with schizophrenia.
This study has finished and is no longer accepting participants.
In BeijingA Multicenter, Randomized, Double-blind, Active-Controlled Study to Evaluate the Efficacy and Safety of Aripiprazole Intramuscular Depot in the Acute Treatment of Adults With Schizophrenia
This study has finished and is no longer accepting participants.
In BeijingThis study has finished and is no longer accepting participants.
Multiple locations, including BirminghamInterventional, Open-label, Flexible-dose Extension Study of Aripiprazole Once-monthly in Patients With Schizophrenia
This study has finished and is no longer accepting participants.
In San DiegoA 28-week, Randomised, Open-label Study Evaluating the Effectiveness of Aripiprazole Once-monthly Versus Paliperidone Palmitate in Adult Patients With Schizophrenia
This study has finished and is no longer accepting participants.
Multiple locations, including Los AngelesA Multi-Center, Open-Label, Safety and Tolerability Study of Flexible-Dose Oral Aripiprazole (2 Mg-30 mg) in the Treatment of Adolescent Patients With Schizophrenia and Child and Adolescent Patients With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features
This study has finished and is no longer accepting participants.
Multiple locations, including BirminghamWe gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.